Market Update: Clover Health Investments Corp (CLOV) Sees Negative Movement, Closing at 1.11

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Clover Health Investments Corp (NASDAQ: CLOV) closed at $1.11 down -5.13% from its previous closing price of $1.17. In other words, the price has decreased by -$5.13 from its previous closing price. On the day, 2.57 million shares were traded. CLOV stock price reached its highest trading level at $1.18 during the session, while it also had its lowest trading level at $1.1.

Ratios:

For a deeper understanding of Clover Health Investments Corp’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cowen on February 02, 2022, Upgraded its rating to Market Perform and sets its target price to $3 from $7 previously.

On February 02, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $6.

On January 19, 2022, SVB Leerink started tracking the stock assigning a Mkt Perform rating and target price of $3.SVB Leerink initiated its Mkt Perform rating on January 19, 2022, with a $3 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 17 ’24 when Loengard Anna U bought 10,000 shares for $0.93 per share. The transaction valued at 9,300 led to the insider holds 10,000 shares of the business.

Loengard Anna U bought 17,085 shares of CLOV for $16,372 on May 16 ’24. The Director now owns 15,600 shares after completing the transaction at $0.96 per share. On Mar 14 ’24, another insider, Loengard Anna U, who serves as the Director of the company, bought 137,000 shares for $0.73 each. As a result, the insider paid 100,010 and bolstered with 538,841 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLOV now has a Market Capitalization of 575868032 and an Enterprise Value of 213031584. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30 while its Price-to-Book (P/B) ratio in mrq is 1.84. Its current Enterprise Value per Revenue stands at 0.103 whereas that against EBITDA is -1.627.

Stock Price History:

Over the past 52 weeks, CLOV has reached a high of $1.63, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 38.79%, while the 200-Day Moving Average is calculated to be 15.96%.

Shares Statistics:

For the past three months, CLOV has traded an average of 9.28M shares per day and 6285640 over the past ten days. A total of 393.27M shares are outstanding, with a floating share count of 376.01M. Insiders hold about 24.26% of the company’s shares, while institutions hold 18.08% stake in the company. Shares short for CLOV as of 1715731200 were 45327924 with a Short Ratio of 4.88, compared to 1713139200 on 48155925. Therefore, it implies a Short% of Shares Outstanding of 45327924 and a Short% of Float of 11.310001.

Earnings Estimates

The dynamic stock of Clover Health Investments Corp (CLOV) is currently attracting attention from 3.0 analysts actively involved in rating its market status.On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.06, while EPS last year was -$0.06. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.04 and low estimates of -$0.06.

Analysts are recommending an EPS of between -$0.17 and -$0.23 for the fiscal current year, implying an average EPS of -$0.2. EPS for the following year is -$0.21, with 3.0 analysts recommending between -$0.16 and -$0.24.

Revenue Estimates

A total of 3 analysts believe the company’s revenue will be $338.76M this quarter.It ranges from a high estimate of $340.27M to a low estimate of $337.33M. As of the current estimate, Clover Health Investments Corp’s year-ago sales were $513.63MFor the next quarter, 3 analysts are estimating revenue of $329.83M. There is a high estimate of $337.6M for the next quarter, whereas the lowest estimate is $319.85M.

A total of 3 analysts have provided revenue estimates for CLOV’s current fiscal year. The highest revenue estimate was $1.35B, while the lowest revenue estimate was $1.33B, resulting in an average revenue estimate of $1.34B. In the same quarter a year ago, actual revenue was $2.03BBased on 3 analysts’ estimates, the company’s revenue will be $1.38B in the next fiscal year. The high estimate is $1.39B and the low estimate is $1.38B.

Most Popular